Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
107,728,479
-
Share change
-
-70,714
-
Total reported value
-
$1,962,038,029
-
Put/Call ratio
-
111%
-
Price per share
-
$18.26
-
Number of holders
-
300
-
Value change
-
-$1,144,218
-
Number of buys
-
153
-
Number of sells
-
108
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2021
As of 31 Mar 2021,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
300 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,728,479 shares.
The largest 10 holders included
ARK Investment Management LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, PAULSON & CO. INC., NORTHERN TRUST CORP, MACQUARIE GROUP LTD, Parametric Portfolio Associates LLC, Mondrian Investment Partners LTD, RENAISSANCE TECHNOLOGIES LLC, and BANK OF AMERICA CORP /DE/.
This page lists
300
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.